by Philip Wolfson, MD | Sep 27, 2022 | Uncategorized
The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women: Quantification of Ketamine and Metabolites Presented on Tuesday 27th September 2022 | 12.30pm EST | 5.30pm UK Philp Wolfson, Rob Cole, Kara Lynch, Cassandra Yun, Jason Wallach, Julane Andries,...
by Juan Pablo Lopez, PhD | Sep 13, 2022 | Uncategorized
Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2 Presented on Tuesday 13th September 2022 | 12.30pm EST | 5.30pm UK Juan Pablo Lopez, Malte D Lücken, Elena Brivio, Stoyo Karamihalev, Aron Kos, Carlo De Donno, Asaf...
by Thomas Derrick Hull, PhD | Jul 26, 2022 | Uncategorized
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial Presented on Tuesday 26th July 2022 | 12.30pm EST | 5.30pm UK Thomas D Hull,...
by David Mathai, MD and Scott Lee, MD | Jul 12, 2022 | Uncategorized
Mapping consent practices for outpatient psychiatric use of ketamine Presented on Tuesday 12th July 2022 | 12.30pm EST | 5.30pm UK David S Mathai, Scott M Lee, Victoria Mora, Kelley C O’Donnell, Albert Garcia-Romeu, Eric A Storch. J Affect Disord. 2022 Sep...
by Prof David J.R. Foster PhD | Jun 28, 2022 | Uncategorized
Population pharmacokinetics and pharmacodynamics of the therapeutic and adverse effects of ketamine in patients with treatment-refractory depression Presented on Tuesday, 28 June 2022 | 10:00pm (UK time)| 5:00pm (NYC time) | Wednesday, 29 June 2022, 6:30am (Adelaide,...
by Radhika Rawat, MD, PhD | Jun 14, 2022 | Uncategorized
Ketamine activates adult-born immature granule neurons to rapidly alleviate depression-like behaviors in mice Presented on Tuesday 14th June 2022 | 05:30 PM (UK time) | 12:30 PM (EDT NY time) | 09:30 AM (PDT LA time) Radhika Rawat, Elif Tunc-Ozcan, Tammy L. McGuire,...
